Trials / Completed
CompletedNCT00835094
A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)
A Randomized Trial Assessing the Chronobiology of Once Daily Administration of Mometasone Furoate DPI in Patients With Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This will be an open-label, randomized, parallel-group comparison of mometasone furoate dry powder inhaler (MF-DPI) 400 mcg once daily administered in the morning vs. the evening for 12 weeks in subjects with asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mometasone furoate | MF-DPI 400 mcg once daily in the morning for 12 weeks |
| DEVICE | Mometasone furoate | MF-DPI 400 mcg once daily in the evening for 12 weeks |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2009-02-03
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00835094. Inclusion in this directory is not an endorsement.